Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0D5FB
|
||||
Former ID |
DIB014879
|
||||
Drug Name |
EPO-derived peptide
|
||||
Synonyms |
PHBSP; EPO-derived peptide (diabetic retinopathy); EPO helix-B domain peptide (diabetic retinopathy), Araim Pharmaceuticals; EPO-derived peptide (diabetic retinopathy), Araim Pharmaceuticals; Erythropoietin-derived peptide (diabetic retinopathy), Araim Pharmaceuticals
|
||||
Indication | Diabetic retinopathy [ICD9: 250.5; ICD10:H36, E10.3, E11.3, E13.3] | Investigative | [543465] | ||
Company |
Araim Pharmaceuticals Inc
|
||||
Target and Pathway | |||||
Target(s) | Erythropoietin Receptor | Target Info | Modulator | [543465] | |
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Pathway Interaction Database | Signaling events mediated by Stem cell factor receptor (c-Kit) | ||||
EPO signaling pathway | |||||
WikiPathways | EPO Receptor Signaling | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.